Literature DB >> 30343709

Symptoms of PBC - Pathophysiology and management.

Amardeep Khanna1, Jess Leighton2, Lin Lee Wong3, David E Jones4.   

Abstract

Primary biliary cholangitis is a chronic cholestatic liver disease characterised by progressive bile duct damage and, ultimately, biliary cirrhosis. Though up to fifty percent of the patients can be asymptomatic at presentation, symptoms when present are frequently debilitating with significant impact on quality of life and functional status. Characteristic symptoms include pruritus, fatigue and an increasingly recognised mild cognitive impairment. With the exception of pruritus, the "classic" cholestatic symptom, therapeutic options to treat PBC related symptoms are currently limited leaving patients with often significant residual problems. Symptoms can frequently contribute to depression and social isolation further compounding the quality of life impairment. There is need to better understand the current therapeutic options available in order to optimise their use, and to explore newer avenues to understand the pathophysiology of the symptom-generating processed in PBC in order to develop new therapies. Crown
Copyright © 2018. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Fatigue; Primary biliary cholangitis; Pruritus; Quality of life

Mesh:

Substances:

Year:  2018        PMID: 30343709     DOI: 10.1016/j.bpg.2018.06.007

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  7 in total

1.  A Practical Review of Primary Biliary Cholangitis for the Gastroenterologist.

Authors:  Fernanda Q Onofrio; Gideon M Hirschfield; Aliya F Gulamhusein
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-03

2.  Association between Sarcopenia and Depression in Patients with Chronic Liver Diseases.

Authors:  Hiroki Nishikawa; Hirayuki Enomoto; Kazunori Yoh; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kunihiro Hasegawa; Noriko Ishii; Yukihisa Yuri; Takashi Nishimura; Hiroko Iijima; Shuhei Nishiguchi
Journal:  J Clin Med       Date:  2019-05-08       Impact factor: 4.241

3.  Close Correlation between Frailty and Depressive State in Chronic Liver Diseases.

Authors:  Hiroki Nishikawa; Kazunori Yoh; Hirayuki Enomoto; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Yoshihiro Shimono; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kunihiro Hasegawa; Takashi Koriyama; Yukihisa Yuri; Takashi Nishimura; Shuhei Nishiguchi; Hiroko Iijima
Journal:  Medicina (Kaunas)       Date:  2020-06-27       Impact factor: 2.430

4.  ADAM Metalloproteinase Domain 17 Regulates Cholestasis-Associated Liver Injury and Sickness Behavior Development in Mice.

Authors:  Wagdi Almishri; Liam A Swain; Charlotte D'Mello; Tyson S Le; Stefan J Urbanski; Henry H Nguyen
Journal:  Front Immunol       Date:  2022-01-13       Impact factor: 7.561

5.  Symptom patterns in the daily life of PSC patients.

Authors:  Kim N van Munster; Marcel G W Dijkgraaf; Ronald P J Oude Elferink; Ulrich Beuers; Cyriel Y Ponsioen
Journal:  Liver Int       Date:  2022-04-18       Impact factor: 8.754

Review 6.  Understanding fatigue in primary biliary cholangitis: From pathophysiology to treatment perspectives.

Authors:  Erica Nicola Lynch; Claudia Campani; Tommaso Innocenti; Gabriele Dragoni; Maria Rosa Biagini; Paolo Forte; Andrea Galli
Journal:  World J Hepatol       Date:  2022-06-27

Review 7.  Cholestatic pruritus: a knowledge update.

Authors:  Thaís Reginatto Nietsche; Gabriel Dotta; Carlos Baptista Barcaui; Maria Lúcia Cardoso Gomes Ferraz
Journal:  An Bras Dermatol       Date:  2022-03-09       Impact factor: 2.113

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.